COSCIENS Biopharma Inc. Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
COSCIENS Biopharma Inc. (CSCIF) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of $50.65 per share for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-09.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2026-03-25
- COSCIENS Biopharma Inc. weighted average exercise price of share options granted in share-based payment arrangement2019 for the quarter ending 2023-03-31 was $15.00, a 68.92% increase year-over-year.
- COSCIENS Biopharma Inc. weighted average exercise price of share options granted in share-based payment arrangement2019 for the quarter ending 2022-03-31 was $8.88.
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 3 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 3 month as first filed | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 6 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 6 month as first filed | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 9 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 9 month as first filed | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $50.65 20-F · filed 2025-04-09 | |||||||
| 2024-09-30 | $50.65 6-K · filed 2025-11-12 | |||||||
| 2024-06-30 | $50.65 6-K · filed 2025-08-14 | |||||||
| 2023-12-31 | $25.85 20-F · filed 2025-04-09 | $3.75 20-F · filed 2024-03-27 | ||||||
| 2023-09-30 | $19.06 6-K · filed 2024-11-12 | $3.75 6-K · filed 2023-11-09 | ||||||
| 2023-06-30 | $19.00 6-K · filed 2024-08-13 | $3.75 6-K · filed 2023-08-09 | ||||||
| 2023-03-31 | $15.00 6-K · filed 2024-05-16 | $3.75 6-K · filed 2023-05-09 | ||||||
| 2022-12-31 | $21.61 20-F · filed 2025-04-09 | $8.88 20-F · filed 2023-03-23 | ||||||
| 2022-09-30 | $8.88 6-K · filed 2023-11-09 | |||||||
| 2022-06-30 | $8.88 6-K · filed 2023-08-09 | $9.00 6-K/A · filed 2022-08-04 | ||||||
| 2022-03-31 | $8.88 6-K · filed 2023-05-09 | |||||||
| 2021-12-31 | $10.51 20-F/A · filed 2024-07-17 | $10.50 6-K/A · filed 2022-08-04 | ||||||
| 2020-12-31 | $9.15 20-F/A · filed 2024-02-15 |
CAD/shares
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2024-12-31 | 50.65 CAD/shares 20-F · filed 2026-03-25 |
| 2023-12-31 | 25.85 CAD/shares 20-F · filed 2026-03-25 |